The Ecclesia

CRISPR Gene Therapy

2 min read

CRISPR Gene Therapy

Source: Doudna & Charpentier, Science 337, 2012 (Nobel Prize 2020); Cyranoski, Nature 566, 2019 (He Jiankui) Institution: UC Berkeley; University of Vienna; Southern University of Science and Technology, Shenzhen

Finding

CRISPR-Cas9, adapted from bacterial immune defense, enables programmable gene editing. In 2023, the FDA approved Casgevy for sickle cell disease and beta-thalassemia — the first clinical CRISPR therapy, editing patients’ hematopoietic stem cells to reactivate fetal hemoglobin. The technology also applies to germline cells, altering future generations’ DNA. In 2018, He Jiankui created the first gene-edited babies, editing CCR5 for HIV resistance without adequate safety data, institutional oversight, or the children’s consent. Near-universal scientific condemnation followed. He was sentenced to three years in prison.

Pattern Mapping

Proportion — The ultimate proportion question. Somatic editing (one patient’s cells) is proportional: action serves purpose without exceeding it. Germline editing extends beyond the patient, beyond the physician, beyond the current generation. The scope of action exceeds any single person’s or generation’s authority to decide.

Humility — He Jiankui acted unilaterally, without adequate data, without oversight, without consent of those whose genomes he altered. The scientific condemnation was not about the technology but about the scope of authority claimed.

Alignment — Somatic editing: purpose (cure this patient) and action (edit this patient’s cells) are aligned. Germline editing: purpose (eliminate disease) and action (alter future humans without consent) are misaligned — the beneficiary cannot consent.

Connections

  • DNA Error Correction — CRISPR edits the code that error correction protects
  • Apoptosis — both: mechanisms that maintain genetic integrity, now subject to intervention
  • Informed Consent — germline editing is the ultimate informed consent violation
  • CRISPR (LIFE domain) — the bacterial origin: immune memory that became therapeutic tool
  • Atomic Bomb — both: scientific capability that raises the ultimate proportion question

Status

Doudna & Charpentier (2012; Nobel 2020). Casgevy: FDA December 2023. He Jiankui: Cyranoski (2019); sentenced 2019. National Academies, Human Genome Editing (2017). Ethical status of germline editing is genuinely contested (MYSTERY_EXPLORATION). The mapping to the five properties is this project’s structural interpretation.

The mapping to the five properties is this project’s structural interpretation.

Graph View

Backlinks